Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness
Dr. Paul Yang, of Casey Eye Institute, joins to discuss new ARVO 2021 data supporting the gene therapy for X-linked retinitis pigmentosa.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.